Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
USPH Stock Forecast 2026-2027
$86.00
Current Price
$1.31B
Market Cap
Buy 6
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to USPH Price Targets
+31.4%
To High Target of $113.00
+22.7%
To Median Target of $105.50
+14.0%
To Low Target of $98.00
USPH Price Momentum
+2.0%
1 Week Change
+10.5%
1 Month Change
-2.9%
1 Year Change
+10.1%
Year-to-Date Change
-8.0%
From 52W High of $93.50
+37.0%
From 52W Low of $62.77
📊 TOP ANALYST CALLS
Did USPH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if US Physical Therapy is one of their latest high-conviction picks.
Latest USPH Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, USPH has a bullish consensus with a median price target of $105.50 (ranging from $98.00 to $113.00). The overall analyst rating is Strong Buy (8.3/10). Currently trading at $86.00, the median forecast implies a 22.7% upside. This outlook is supported by 6 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Constantine Davides at JMP Securities, projecting a 31.4% upside. Conversely, the most conservative target is provided by Michael Petusky at Barrington Research, suggesting a 14.0% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
USPH Analyst Ratings
6
Buy
1
Hold
0
Sell
USPH Price Target Range
Low
$98.00
Average
$105.50
High
$113.00
Current: $86.00
Latest USPH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for USPH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jan 5, 2026 | Barrington Research | Michael Petusky | Outperform | Maintains | $103.00 |
| Nov 24, 2025 | JP Morgan | Benjamin Rossi | Overweight | Maintains | $100.00 |
| Oct 24, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $103.00 |
| Sep 18, 2025 | JP Morgan | Benjamin Rossi | Overweight | Assumes | $110.00 |
| Aug 8, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $103.00 |
| Jul 1, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $98.00 |
| Apr 22, 2025 | JMP Securities | Constantine Davides | Market Outperform | Reiterates | $113.00 |
| Mar 19, 2025 | JP Morgan | Calvin Sternick | Overweight | Maintains | $110.00 |
| Feb 28, 2025 | Barrington Research | Michael Petusky | Outperform | Maintains | $98.00 |
| Dec 16, 2024 | B of A Securities | Joanna Gajuk | Buy | Upgrade | $115.00 |
| Dec 16, 2024 | JMP Securities | Constantine Davides | Market Outperform | Initiates | $113.00 |
| Dec 3, 2024 | JP Morgan | Calvin Sternick | Overweight | Maintains | $120.00 |
| Nov 21, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $108.00 |
| Nov 7, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $108.00 |
| Oct 9, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $108.00 |
| Oct 7, 2024 | B of A Securities | Joanna Gajuk | Neutral | Downgrade | $90.00 |
| Sep 20, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $108.00 |
| Aug 15, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $108.00 |
| May 9, 2024 | Barrington Research | Michael Petusky | Outperform | Maintains | $122.00 |
| Mar 13, 2024 | JP Morgan | Calvin Sternick | Overweight | Maintains | $117.00 |
U.S. Physical Therapy Inc. (USPH) Competitors
The following stocks are similar to US Physical Therapy based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
USPH
US Physical Therapy
mkt cap
1.31B
U.S. Physical Therapy Inc. (USPH) Financial Data
U.S. Physical Therapy Inc. has a market capitalization of $1.31B with a P/E ratio of 36.3x. The company generates $750.95M in trailing twelve-month revenue with a 5.9% profit margin.
Revenue growth is +17.3% quarter-over-quarter, while maintaining an operating margin of +10.0% and return on equity of +8.4%.
Valuation Metrics
Market Cap
$1.31B
Enterprise Value
$1.86B
P/E Ratio
36.3x
PEG Ratio
1.6x
Price/Sales
1.7x
Growth & Margins
Revenue Growth (YoY)
+17.3%
Gross Margin
+18.7%
Operating Margin
+10.0%
Net Margin
+5.9%
EPS Growth
+98.2%
Financial Health
Cash/Price Ratio
+2.5%
Current Ratio
1.2x
Debt/Equity
39.4x
ROE
+8.4%
ROA
+4.3%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
U.S. Physical Therapy Inc. (USPH) Business Model
About U.S. Physical Therapy Inc.
What They Do
Operates outpatient physical therapy clinics.
Business Model
The company generates revenue by providing rehabilitation services through its network of outpatient clinics. They focus on patient-centered care and collaborate with hospitals, physicians, and employers to offer tailored therapy solutions, which allows them to capture a broad market of individuals in need of physical rehabilitation.
Additional Information
U.S. Physical Therapy plays a vital role in the healthcare sector, addressing the increasing demand for physical therapy services due to an aging population and heightened awareness of rehabilitation benefits. Headquartered in Houston, Texas, the company emphasizes evidence-based treatment practices to enhance patient mobility and quality of life.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
4,034
CEO
Mr. Christopher J. Reading
Country
United States
IPO Year
1992
Website
www.usph.comU.S. Physical Therapy Inc. (USPH) Latest News & Analysis
Latest News
Quick Summary
U.S. Physical Therapy, Inc. (USPH) announced CEO Chris Reading presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. The company operates 780 outpatient clinics.
Why It Matters
Chris Reading's presentation at a major healthcare conference can signal strategic developments, influencing investor sentiment and potential stock performance for U.S. Physical Therapy.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Investors should monitor USPH stock due to recent activity in the options market, indicating potential significant movements.
Why It Matters
Recent options market activity suggests heightened interest or volatility in USPH stock, indicating potential price movements that could impact investment strategies.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
U.S. Physical Therapy, Inc. (USPH) has acquired a 50% interest in a physical therapy management company, managing eight clinics with $8 million in annual revenues and 66,000 visits.
Why It Matters
The acquisition expands USPH's market presence and revenue potential, enhancing growth prospects and operational scale, which can positively impact stock performance and investor confidence.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Investors in Medical - Outpatient and Home Healthcare stocks may consider Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH) for potential value opportunities.
Why It Matters
The comparison between Addus HomeCare and U.S. Physical Therapy highlights potential investment opportunities, influencing stock selection and portfolio strategies in the healthcare sector.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
4D Advisors, LLC acquired 110,000 shares of USPH, increasing their position value by $9.34 million, a 4.97% change in their 13F reportable assets.
Why It Matters
4D Advisors' significant acquisition of USPH shares signals confidence in the company's future, potentially impacting stock performance and attracting further investor interest.
Source: The Motley Fool
Market Sentiment:
Neutral
Quick Summary
Investors in Medical - Outpatient and Home Healthcare sectors should consider Addus HomeCare (ADUS) and U.S. Physical Therapy (USPH) for potential value.
Why It Matters
The comparison between Addus HomeCare and U.S. Physical Therapy highlights potential investment opportunities in the outpatient and home healthcare sector, crucial for value-focused strategies.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About USPH Stock
What is U.S. Physical Therapy Inc.'s (USPH) stock forecast for 2026?
Based on our analysis of 10 Wall Street analysts, U.S. Physical Therapy Inc. (USPH) has a median price target of $105.50. The highest price target is $113.00 and the lowest is $98.00.
Is USPH stock a good investment in 2026?
According to current analyst ratings, USPH has 6 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $86.00. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for USPH stock?
Wall Street analysts predict USPH stock could reach $105.50 in the next 12 months. This represents a 22.7% increase from the current price of $86.00. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is U.S. Physical Therapy Inc.'s business model?
The company generates revenue by providing rehabilitation services through its network of outpatient clinics. They focus on patient-centered care and collaborate with hospitals, physicians, and employers to offer tailored therapy solutions, which allows them to capture a broad market of individuals in need of physical rehabilitation.
What is the highest forecasted price for USPH U.S. Physical Therapy Inc.?
The highest price target for USPH is $113.00 from Constantine Davides at JMP Securities, which represents a 31.4% increase from the current price of $86.00.
What is the lowest forecasted price for USPH U.S. Physical Therapy Inc.?
The lowest price target for USPH is $98.00 from Michael Petusky at Barrington Research, which represents a 14.0% increase from the current price of $86.00.
What is the overall USPH consensus from analysts for U.S. Physical Therapy Inc.?
The overall analyst consensus for USPH is bullish. Out of 10 Wall Street analysts, 6 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $105.50.
How accurate are USPH stock price projections?
Stock price projections, including those for U.S. Physical Therapy Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: January 19, 2026 3:51 AM UTC